Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Monoclonal | 20 | 2023 | 65 | 5.600 |
Why?
|
| Lyme Disease | 6 | 2023 | 9 | 3.000 |
Why?
|
| Enterotoxigenic Escherichia coli | 7 | 2023 | 8 | 2.880 |
Why?
|
| Escherichia coli Infections | 6 | 2023 | 9 | 2.430 |
Why?
|
| Antibodies, Bacterial | 7 | 2023 | 42 | 2.360 |
Why?
|
| Lipoproteins | 6 | 2022 | 11 | 2.090 |
Why?
|
| Bacterial Outer Membrane Proteins | 6 | 2023 | 36 | 2.070 |
Why?
|
| Bacterial Vaccines | 5 | 2022 | 22 | 2.010 |
Why?
|
| Animals | 30 | 2023 | 1959 | 1.980 |
Why?
|
| Borrelia burgdorferi | 5 | 2023 | 5 | 1.960 |
Why?
|
| Epitopes | 7 | 2022 | 41 | 1.910 |
Why?
|
| Antibodies, Neutralizing | 6 | 2021 | 33 | 1.840 |
Why?
|
| Immunoglobulin A | 4 | 2022 | 8 | 1.830 |
Why?
|
| Antigens, Surface | 5 | 2022 | 15 | 1.630 |
Why?
|
| Single-Domain Antibodies | 2 | 2022 | 2 | 1.630 |
Why?
|
| Escherichia coli Vaccines | 3 | 2021 | 4 | 1.590 |
Why?
|
| Immunoglobulin A, Secretory | 6 | 2023 | 6 | 1.510 |
Why?
|
| Diarrhea | 3 | 2021 | 12 | 1.510 |
Why?
|
| Mice | 22 | 2023 | 1008 | 1.490 |
Why?
|
| Humans | 30 | 2023 | 3987 | 1.400 |
Why?
|
| Antibodies, Viral | 7 | 2023 | 59 | 1.370 |
Why?
|
| Rabies virus | 2 | 2022 | 2 | 1.240 |
Why?
|
| Spike Glycoprotein, Coronavirus | 4 | 2023 | 8 | 1.220 |
Why?
|
| Amino Acid Substitution | 4 | 2021 | 33 | 1.070 |
Why?
|
| Immunoglobulin G | 7 | 2023 | 63 | 0.850 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2019 | 8 | 0.850 |
Why?
|
| Rabies | 1 | 2022 | 1 | 0.850 |
Why?
|
| Rabies Vaccines | 1 | 2022 | 1 | 0.850 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2022 | 2 | 0.850 |
Why?
|
| Ticks | 4 | 2023 | 5 | 0.800 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 222 | 0.780 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 3 | 0.750 |
Why?
|
| Betacoronavirus | 1 | 2020 | 9 | 0.740 |
Why?
|
| Hepacivirus | 2 | 2017 | 7 | 0.720 |
Why?
|
| Viral Envelope Proteins | 4 | 2017 | 16 | 0.690 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 20 | 0.670 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 2017 | 1 | 0.610 |
Why?
|
| Enteroendocrine Cells | 2 | 2007 | 4 | 0.600 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2016 | 6 | 0.570 |
Why?
|
| Protein Binding | 5 | 2020 | 187 | 0.560 |
Why?
|
| Disease Transmission, Infectious | 1 | 2016 | 5 | 0.550 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2016 | 4 | 0.550 |
Why?
|
| Immunologic Factors | 1 | 2016 | 4 | 0.550 |
Why?
|
| Immunotherapy | 2 | 2021 | 17 | 0.500 |
Why?
|
| Mice, Transgenic | 6 | 2021 | 149 | 0.480 |
Why?
|
| Protein Engineering | 1 | 2014 | 10 | 0.470 |
Why?
|
| HEK293 Cells | 4 | 2020 | 108 | 0.470 |
Why?
|
| Corynebacterium diphtheriae | 1 | 2013 | 1 | 0.460 |
Why?
|
| Diphtheria | 1 | 2013 | 1 | 0.460 |
Why?
|
| Diphtheria Antitoxin | 1 | 2013 | 1 | 0.460 |
Why?
|
| Models, Molecular | 3 | 2020 | 120 | 0.430 |
Why?
|
| Antigens, Viral | 1 | 2011 | 23 | 0.390 |
Why?
|
| Glycoproteins | 1 | 2011 | 35 | 0.390 |
Why?
|
| Serotonin | 2 | 2007 | 11 | 0.380 |
Why?
|
| Immunization, Passive | 3 | 2023 | 9 | 0.370 |
Why?
|
| Escherichia coli Proteins | 2 | 2021 | 23 | 0.360 |
Why?
|
| Cell Differentiation | 4 | 2018 | 188 | 0.360 |
Why?
|
| Gastrointestinal Tract | 2 | 2020 | 8 | 0.350 |
Why?
|
| Drug Design | 2 | 2021 | 12 | 0.340 |
Why?
|
| Mutation | 4 | 2020 | 246 | 0.340 |
Why?
|
| Mice, Inbred C3H | 3 | 2019 | 12 | 0.340 |
Why?
|
| Lyme Disease Vaccines | 3 | 2023 | 3 | 0.330 |
Why?
|
| Male | 4 | 2021 | 1734 | 0.330 |
Why?
|
| Wnt Proteins | 2 | 2007 | 23 | 0.310 |
Why?
|
| Epitope Mapping | 2 | 2021 | 6 | 0.310 |
Why?
|
| Gastrointestinal Hormones | 1 | 2007 | 1 | 0.310 |
Why?
|
| Retinoblastoma Protein | 1 | 2007 | 6 | 0.300 |
Why?
|
| Antibody Specificity | 2 | 2020 | 17 | 0.300 |
Why?
|
| Multipotent Stem Cells | 1 | 2007 | 2 | 0.300 |
Why?
|
| Adenoma | 1 | 2007 | 6 | 0.300 |
Why?
|
| Cell Cycle | 1 | 2007 | 44 | 0.300 |
Why?
|
| beta Catenin | 1 | 2007 | 19 | 0.300 |
Why?
|
| Liver Transplantation | 3 | 2016 | 6 | 0.290 |
Why?
|
| Administration, Oral | 3 | 2023 | 27 | 0.280 |
Why?
|
| Epitopes, B-Lymphocyte | 2 | 2023 | 5 | 0.270 |
Why?
|
| Transfection | 2 | 2019 | 70 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 3 | 2013 | 68 | 0.250 |
Why?
|
| Hepatitis C Antibodies | 2 | 2016 | 2 | 0.250 |
Why?
|
| Hepatitis C | 2 | 2016 | 7 | 0.250 |
Why?
|
| Caco-2 Cells | 2 | 2021 | 4 | 0.240 |
Why?
|
| Neutralization Tests | 3 | 2013 | 15 | 0.240 |
Why?
|
| Diphtheria Toxin | 2 | 2014 | 2 | 0.230 |
Why?
|
| Hepatitis C, Chronic | 2 | 2014 | 5 | 0.230 |
Why?
|
| Female | 5 | 2021 | 1951 | 0.220 |
Why?
|
| Borrelia burgdorferi Group | 1 | 2022 | 1 | 0.220 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2022 | 1 | 0.210 |
Why?
|
| Cells, Cultured | 4 | 2018 | 219 | 0.210 |
Why?
|
| Dogs | 1 | 2022 | 42 | 0.210 |
Why?
|
| Macaca fascicularis | 1 | 2021 | 4 | 0.200 |
Why?
|
| Macaca mulatta | 1 | 2021 | 34 | 0.200 |
Why?
|
| Mutation, Missense | 1 | 2021 | 29 | 0.200 |
Why?
|
| Antiviral Agents | 2 | 2023 | 31 | 0.190 |
Why?
|
| Camelids, New World | 1 | 2021 | 1 | 0.190 |
Why?
|
| Immunoconjugates | 1 | 2021 | 1 | 0.190 |
Why?
|
| Fimbriae Proteins | 1 | 2021 | 1 | 0.190 |
Why?
|
| Cross Protection | 1 | 2021 | 1 | 0.190 |
Why?
|
| Vero Cells | 1 | 2020 | 13 | 0.190 |
Why?
|
| Cross Reactions | 1 | 2020 | 23 | 0.190 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 15 | 0.190 |
Why?
|
| Aotidae | 1 | 2020 | 2 | 0.180 |
Why?
|
| Receptors, IgE | 1 | 2019 | 1 | 0.180 |
Why?
|
| Hypersensitivity | 1 | 2019 | 7 | 0.180 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 6 | 0.180 |
Why?
|
| Mice, SCID | 1 | 2019 | 29 | 0.170 |
Why?
|
| Plasmids | 1 | 2019 | 39 | 0.170 |
Why?
|
| Exosomes | 1 | 2018 | 4 | 0.160 |
Why?
|
| Treatment Outcome | 2 | 2016 | 286 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2007 | 14 | 0.150 |
Why?
|
| Structural Homology, Protein | 1 | 2016 | 2 | 0.140 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 29 | 0.140 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 23 | 0.140 |
Why?
|
| Secondary Prevention | 1 | 2016 | 12 | 0.140 |
Why?
|
| Binding Sites | 1 | 2016 | 111 | 0.140 |
Why?
|
| Tick Bites | 1 | 2016 | 2 | 0.140 |
Why?
|
| Cell Line | 2 | 2013 | 238 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 81 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 1 | 0.130 |
Why?
|
| Pregnancy Proteins | 1 | 2015 | 2 | 0.130 |
Why?
|
| Pre-Eclampsia | 1 | 2015 | 3 | 0.130 |
Why?
|
| Receptors, Fc | 1 | 2015 | 4 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2015 | 7 | 0.130 |
Why?
|
| Biological Evolution | 1 | 2014 | 12 | 0.120 |
Why?
|
| Gels | 1 | 2014 | 1 | 0.120 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2014 | 2 | 0.120 |
Why?
|
| Biomarkers | 1 | 2014 | 79 | 0.120 |
Why?
|
| Glutamic Acid | 1 | 2014 | 8 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 20 | 0.120 |
Why?
|
| Lysine | 1 | 2014 | 8 | 0.120 |
Why?
|
| Static Electricity | 1 | 2014 | 16 | 0.120 |
Why?
|
| Temperature | 1 | 2014 | 23 | 0.120 |
Why?
|
| Guinea Pigs | 1 | 2013 | 6 | 0.120 |
Why?
|
| Healthy Volunteers | 1 | 2013 | 6 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2013 | 28 | 0.110 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 7 | 0.110 |
Why?
|
| Intestines | 1 | 2013 | 12 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 21 | 0.110 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 15 | 0.110 |
Why?
|
| Mammals | 2 | 2023 | 17 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2023 | 50 | 0.100 |
Why?
|
| Binding Sites, Antibody | 1 | 2011 | 4 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 27 | 0.100 |
Why?
|
| Point Mutation | 1 | 2011 | 20 | 0.100 |
Why?
|
| Sequence Analysis, Protein | 1 | 2011 | 14 | 0.100 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 56 | 0.100 |
Why?
|
| Asparagine | 1 | 2011 | 9 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2023 | 61 | 0.090 |
Why?
|
| RNA, Viral | 3 | 2016 | 38 | 0.090 |
Why?
|
| Mice, Knockout | 2 | 2008 | 236 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2008 | 290 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 90 | 0.090 |
Why?
|
| Gastrin-Secreting Cells | 1 | 2008 | 1 | 0.080 |
Why?
|
| Glycosylation | 2 | 2021 | 31 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 54 | 0.080 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2007 | 1 | 0.080 |
Why?
|
| Ghrelin | 1 | 2007 | 2 | 0.080 |
Why?
|
| Antibody Affinity | 2 | 2021 | 3 | 0.080 |
Why?
|
| Cricetulus | 2 | 2019 | 12 | 0.080 |
Why?
|
| CHO Cells | 2 | 2019 | 17 | 0.080 |
Why?
|
| Sequence Deletion | 1 | 2007 | 18 | 0.070 |
Why?
|
| Exons | 1 | 2007 | 27 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2008 | 232 | 0.070 |
Why?
|
| Middle Aged | 2 | 2021 | 938 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 9 | 0.060 |
Why?
|
| Receptors, LDL | 1 | 2004 | 5 | 0.060 |
Why?
|
| Zebrafish Proteins | 1 | 2004 | 22 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2023 | 13 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 2023 | 31 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 193 | 0.060 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 6 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 11 | 0.060 |
Why?
|
| Lung | 1 | 2023 | 28 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 39 | 0.050 |
Why?
|
| Agglutination | 1 | 2022 | 1 | 0.050 |
Why?
|
| Propidium | 1 | 2022 | 1 | 0.050 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2022 | 7 | 0.050 |
Why?
|
| Immune Sera | 1 | 2022 | 6 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 132 | 0.050 |
Why?
|
| Child | 1 | 2023 | 253 | 0.050 |
Why?
|
| Protein Domains | 1 | 2022 | 12 | 0.050 |
Why?
|
| Bacterial Adhesion | 1 | 2021 | 3 | 0.050 |
Why?
|
| Gastric Acid | 1 | 2021 | 2 | 0.050 |
Why?
|
| Plants, Genetically Modified | 1 | 2021 | 2 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 91 | 0.050 |
Why?
|
| Chromatography, Affinity | 1 | 2020 | 6 | 0.050 |
Why?
|
| Protein Multimerization | 1 | 2020 | 20 | 0.050 |
Why?
|
| Drug Compounding | 1 | 2019 | 2 | 0.040 |
Why?
|
| Drug Stability | 1 | 2019 | 4 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 32 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2018 | 4 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 2018 | 2 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 15 | 0.040 |
Why?
|
| Proteome | 1 | 2018 | 24 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2018 | 37 | 0.040 |
Why?
|
| Adult | 1 | 2021 | 921 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2013 | 314 | 0.040 |
Why?
|
| Neurons | 1 | 2018 | 136 | 0.040 |
Why?
|
| Sofosbuvir | 1 | 2016 | 1 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2016 | 1 | 0.040 |
Why?
|
| Sustained Virologic Response | 1 | 2016 | 3 | 0.040 |
Why?
|
| Allografts | 1 | 2016 | 3 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2016 | 3 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2016 | 12 | 0.040 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 10 | 0.040 |
Why?
|
| Amniotic Fluid | 1 | 2015 | 1 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2015 | 31 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2015 | 21 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 61 | 0.030 |
Why?
|
| Half-Life | 1 | 2015 | 3 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2015 | 13 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 61 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 88 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 121 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 37 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 45 | 0.030 |
Why?
|
| Recurrence | 1 | 2014 | 36 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 41 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 119 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 89 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 236 | 0.030 |
Why?
|
| Zinc Finger Protein Gli3 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2013 | 6 | 0.030 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Mesoderm | 1 | 2013 | 14 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2013 | 7 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 10 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 14 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 12 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2013 | 72 | 0.030 |
Why?
|
| Tetraspanin 28 | 1 | 2012 | 1 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 89 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 2012 | 8 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2013 | 51 | 0.030 |
Why?
|
| Viral Load | 1 | 2012 | 44 | 0.030 |
Why?
|
| Pyloric Antrum | 1 | 2008 | 1 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2008 | 7 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 37 | 0.020 |
Why?
|
| Base Sequence | 1 | 2008 | 155 | 0.020 |
Why?
|
| Gene Expression | 1 | 2008 | 96 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2008 | 160 | 0.020 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2004 | 4 | 0.020 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2004 | 4 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 47 | 0.010 |
Why?
|
| Proteins | 1 | 2004 | 102 | 0.010 |
Why?
|